Icon

RECORLEV (nda214133)- (150MG)

LEVOKETOCONAZOLE STRONGBRIDGE
150MG
No No
2040-Mar-02 Expired
None None
None No
RECORLEV is a cortisol synthesis inhibitor indicated for the treatment of endogenous hypercortisolemia in adult patients with Cushing’s syndrome for whom surgery is not an option or has not been curative.
0 0 0
Total Other Developers 2
Drugs with Suitability No
150MG ** ** - - -
NDA Sales Available Total Generic Sales Available
Yes 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search





Expired
to
Expired
to


Please contact contact@researchdelta.com to get more details.